Synthetic NKG2D receptor (SNR) armored CAR-T cells overcome antigen heterogeneity of solid tumor.

Cell Oncol (Dordr) · 2025 · PMC12528229 · PMID 40536708

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In this model, both types of CAR-T cells were potent in controlling tumor growth; however, SNR CAR-T cells showed a trend towards more effective T cell expansion and superior control of tumor growth (Fig. 5e–f).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.